Akso Health Group ADR (AHG)vsCardinal Health Inc (CAH)
AHG
Akso Health Group ADR
$2.36
-2.48%
HEALTHCARE · Cap: $807.33M
CAH
Cardinal Health Inc
$207.83
-1.47%
HEALTHCARE · Cap: $48.91B
Smart Verdict
WallStSmart Research — data-driven comparison
Cardinal Health Inc generates 1655579% more annual revenue ($244.67B vs $14.78M). CAH leads profitability with a 68.0% profit margin vs 0.0%. CAH earns a higher WallStSmart Score of 53/100 (C-).
AHG
Avoid24
out of 100
Grade: F
CAH
Buy53
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for AHG.
Margin of Safety
+13.6%
Fair Value
$259.58
Current Price
$207.83
$51.75 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 415.8% year-over-year
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Keeps 68 of every $100 in revenue as profit
Strong operational efficiency at 123.0%
Safe zone — low bankruptcy risk
18.8% revenue growth
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
Premium valuation, high expectations priced in
ROE of 0.0% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : AHG
The strongest argument for AHG centers on Revenue Growth, Debt/Equity, Altman Z-Score. Revenue growth of 415.8% demonstrates continued momentum.
Bull Case : CAH
The strongest argument for CAH centers on Profit Margin, Operating Margin, Altman Z-Score. Profitability is solid with margins at 68.0% and operating margin at 123.0%. Revenue growth of 18.8% demonstrates continued momentum.
Bear Case : AHG
The primary concerns for AHG are EPS Growth, Market Cap, Profit Margin.
Bear Case : CAH
The primary concerns for CAH are P/E Ratio, Return on Equity.
Key Dynamics to Monitor
AHG profiles as a hypergrowth stock while CAH is a growth play — different risk/reward profiles.
CAH carries more volatility with a beta of 0.62 — expect wider price swings.
AHG is growing revenue faster at 415.8% — sustainability is the question.
CAH generates stronger free cash flow (555M), providing more financial flexibility.
Bottom Line
CAH scores higher overall (53/100 vs 24/100), backed by strong 68.0% margins and 18.8% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Akso Health Group ADR
HEALTHCARE · MEDICAL DISTRIBUTION · China
Akso Health Group ADR is a leading entity in the healthcare sector, focused on delivering innovative medical solutions and integrated patient care services. With a specialization in advanced health technologies, the company is well-positioned to tap into growth opportunities in telehealth and personalized medicine, bolstered by a strong commitment to research and development. Its robust business model and dedication to quality, supported by a skilled team of professionals, make Akso Health Group an appealing investment for institutional investors aiming to navigate the transformative landscape of healthcare.
Visit Website →Cardinal Health Inc
HEALTHCARE · MEDICAL DISTRIBUTION · USA
Cardinal Health, Inc. is an American multinational health care services company.
Visit Website →Compare with Other MEDICAL DISTRIBUTION Stocks
Want to dig deeper into these stocks?